Literature DB >> 20452406

Acute withdrawal from chronic escalating-dose binge cocaine administration alters kappa opioid receptor stimulation of [35S] guanosine 5'-O-[gamma-thio]triphosphate acid binding in the rat ventral tegmental area.

A P Piras1, Y Zhou, S D Schlussman, A Ho, M J Kreek.   

Abstract

There is evidence that the kappa opioid system plays an important role in cocaine addiction and that chronic cocaine administration and withdrawal from chronic cocaine alter kappa opioid receptor (KOPr) density. The present study employed in situ [(35)S]guanosine 5'-O-[gamma-thio]triphosphate acid (GTPgammaS) binding autoradiography to measure KOPr-stimulated activation of G-protein in the caudate putamen, nucleus accumbens core and shell, lateral hypothalamus, basolateral amygdala, substantia nigra compacta, substantia nigra reticulata and ventral tegmental area (VTA), in response to chronic cocaine administration or acute and chronic withdrawal from chronic cocaine. Male Fischer rats were injected i.p. with saline or cocaine three times daily at 1 h intervals in an escalating-dose paradigm for 14 days (from 3x15 mg/kg/injection on days 1-3 up to 3x30 mg/kg/injection on days 10-14). Identically treated separate groups were withdrawn from cocaine or saline for 24 h or 14 days. No significant change in KOPr agonist U-69593-stimulated [(35)S]GTPgammaS was found in the seven regions studied 30 min or 14 days after chronic 14 days escalating-dose binge cocaine administration. However there was an increase in KOPr -stimulated [(35)S]GTPgammaS binding in the VTA (P<0.01) of rats withdrawn for 24 h from chronic cocaine. Our results show a cocaine withdrawal induced increase of KOPr signaling in the VTA, and suggest that the KOPr may play a role in acute withdrawal from cocaine. Copyright (c)10 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20452406      PMCID: PMC3716394          DOI: 10.1016/j.neuroscience.2010.04.060

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  49 in total

1.  Effects of a newly synthesized kappa-opioid receptor agonist, TRK-820, on the discriminative stimulus and rewarding effects of cocaine in rats.

Authors:  Tomohisa Mori; Mutsuko Nomura; Hiroshi Nagase; Minoru Narita; Tsutomu Suzuki
Journal:  Psychopharmacology (Berl)       Date:  2002-02-12       Impact factor: 4.530

Review 2.  Drug-activation of brain reward pathways.

Authors:  R A Wise
Journal:  Drug Alcohol Depend       Date:  1998 Jun-Jul       Impact factor: 4.492

3.  Repeated cocaine administration upregulates kappa and mu, but not delta, opioid receptors.

Authors:  E M Unterwald; J M Rubenfeld; M J Kreek
Journal:  Neuroreport       Date:  1994-08-15       Impact factor: 1.837

4.  Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study.

Authors:  A Mansour; C A Fox; S Burke; F Meng; R C Thompson; H Akil; S J Watson
Journal:  J Comp Neurol       Date:  1994-12-15       Impact factor: 3.215

5.  Effect of 6-hydroxydopamine lesions of the medial prefrontal cortex on intravenous cocaine self-administration under a progressive ratio schedule of reinforcement.

Authors:  A McGregor; G Baker; D C Roberts
Journal:  Pharmacol Biochem Behav       Date:  1996-01       Impact factor: 3.533

6.  Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies.

Authors:  D P Devine; P Leone; D Pocock; R A Wise
Journal:  J Pharmacol Exp Ther       Date:  1993-09       Impact factor: 4.030

7.  Effects of repeated psychostimulant administration on the prodynorphin system activity and kappa opioid receptor density in the rat brain.

Authors:  J Turchan; B Przewłocka; W Lasoń; R Przewłocki
Journal:  Neuroscience       Date:  1998-08       Impact factor: 3.590

8.  Acute tolerance to the dopamine response induced by a binge pattern of cocaine administration in male rats: an in vivo microdialysis study.

Authors:  I M Maisonneuve; M J Kreek
Journal:  J Pharmacol Exp Ther       Date:  1994-02       Impact factor: 4.030

9.  In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5'-[gamma-[35S]thio]-triphosphate binding.

Authors:  L J Sim; D E Selley; S R Childers
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

10.  Both dynorphin A(1-17) and [Des-Tyr1]dynorphin A(2-17) inhibit adenylyl cyclase activity in rat caudate putamen.

Authors:  L H Claye; E M Unterwald; A Ho; M J Kreek
Journal:  J Pharmacol Exp Ther       Date:  1996-04       Impact factor: 4.030

View more
  11 in total

Review 1.  The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

Authors:  H A Tejeda; T S Shippenberg; R Henriksson
Journal:  Cell Mol Life Sci       Date:  2011-10-16       Impact factor: 9.261

2.  Blockade of kappa opioid receptors attenuates the development of depressive-like behaviors induced by cocaine withdrawal in rats.

Authors:  Elena Chartoff; Allison Sawyer; Anna Rachlin; Dave Potter; Andrea Pliakas; William A Carlezon
Journal:  Neuropharmacology       Date:  2011-06-29       Impact factor: 5.250

3.  Tolerance and sensitization to chronic escalating dose heroin following extended withdrawal in Fischer rats: possible role of mu-opioid receptors.

Authors:  Katharine M Seip-Cammack; Brian Reed; Yong Zhang; Ann Ho; Mary Jeanne Kreek
Journal:  Psychopharmacology (Berl)       Date:  2012-07-25       Impact factor: 4.530

Review 4.  κ-opioid receptor/dynorphin system: genetic and pharmacotherapeutic implications for addiction.

Authors:  Eduardo R Butelman; Vadim Yuferov; Mary Jeanne Kreek
Journal:  Trends Neurosci       Date:  2012-06-16       Impact factor: 13.837

5.  "Effects of the novel relatively short-acting kappa opioid receptor antagonist LY2444296 in behaviors observed after chronic extended-access cocaine self-administration in rats".

Authors:  Marta Valenza; Eduardo R Butelman; Mary Jeanne Kreek
Journal:  Psychopharmacology (Berl)       Date:  2017-05-27       Impact factor: 4.530

Review 6.  Drug withdrawal conceptualized as a stressor.

Authors:  Elena H Chartoff; William A Carlezon
Journal:  Behav Pharmacol       Date:  2014-09       Impact factor: 2.293

7.  Regional differences in mu and kappa opioid receptor G-protein activation in brain in male and female prairie voles.

Authors:  T J Martin; T Sexton; S A Kim; A L Severino; C M Peters; L J Young; S R Childers
Journal:  Neuroscience       Date:  2015-10-30       Impact factor: 3.590

8.  Dynorphin Counteracts Orexin in the Paraventricular Nucleus of the Thalamus: Cellular and Behavioral Evidence.

Authors:  Alessandra Matzeu; Marsida Kallupi; Olivier George; Paul Schweitzer; Rémi Martin-Fardon
Journal:  Neuropsychopharmacology       Date:  2017-10-20       Impact factor: 7.853

9.  KOR Control over Addiction Processing: An Exploration of the Mesolimbic Dopamine Pathway.

Authors:  Paige M Estave; Mary B Spodnick; Anushree N Karkhanis
Journal:  Handb Exp Pharmacol       Date:  2022

10.  Expression of protein kinase A and the kappa opioid receptor in selected brain regions and conditioned place aversion in morphine-dependent rats.

Authors:  Xiuhua Song; Wenqiang Li; Yuzhong Shi; Jingdan Zhang; Yi Li
Journal:  Oncotarget       Date:  2017-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.